FW: Updated CDC Guidance – 02/15/2021
Sent on behalf of the Division of Public Health, Communicable Disease Branch 

  • We continue to recommend the use of appropriate PPE including NIOSH-approved N95 respirator (or equivalent or higher level respirator), gown, gloves, and eye protection when caring for patients with suspected or confirmed SARS-CoV-2 infection.
  • For source control, we / CDC continues to recommend universal use of well-fitting source control for everyone in a healthcare setting. Healthcare personnel options for source control include:
  • N95 respirators or equivalent or high-level respirators
  • A respirator approved under standards used in other countries that are similar to NIOSH-approved N95 filtering facepiece respirators OR
  • A well-fitting facemask (e.g., selection of a facemask with a nose wire to help the facemask conform to the face; selection of a facemask with ties rather than ear loops; use of a mask fitter; tying the facemask’s ear loops and tucking in the side pleats; fastening the facemask’s ear loops behind the wearer’s head; use of a cloth mask over the facemask to help it conform to the wearer’s face)
Updated quarantine guidance for vaccinated persons. This guidance states that vaccinated persons with an exposure to someone with suspected or confirmed COVID-19 are not required to quarantine if they meet all of the following criteria:
  1. Are fully vaccinated (i.e., ≥2 weeks following receipt of the second dose in a 2-dose series, or ≥2 weeks following receipt of one dose of a single-dose vaccine) AND
  2. Are within 3 months following receipt of the last dose in the series AND
  3. Have remained asymptomatic since the current COVID-19 exposure.
  •  These updated quarantine criteria could be applied when considering work restrictions for fully vaccinated healthcare personnel with higher-risk exposures as a strategy to alleviate staffing shortages.              
  • Residents/patients: Vaccinated inpatients and residents in healthcare settings should continue to quarantine following an exposure to someone with suspected or confirmed COVID-19. This exception is due to the unknown vaccine effectiveness in this population, the higher risk of severe disease and death, and challenges with social distancing in healthcare settings.
  • This applies to new admissions.